Clinical Trial Update: Intra-articular I-PRF Injections in Patients With Temporomandibular Joint Dysfunction [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating intra-articular injections of platelet-rich fibrin (I-PRF) for temporomandibular disorders has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Temporomandibular Disorders

Drugs mentioned

• I-PRF intra-articular injections (platelet-rich fibrin)

Snippet

Sponsor: Hospital of the Ministry of Interior, Kielce, Poland | Conditions: Temporomandibular Joint Disorders, Temporomandibular Joint Pain | Phase 2 | Status: COMPLETED